BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Drug Development

  Incyte Corporation Release: First FDA-Approved Treatment for Myelofibrosis, Jakafi™ (ruxolitinib), Discussed in Multiple Presentations at 2011 American Society of Hematology Annual Meeting

  December 12, 2011

   · 

  1 min read
• Drug Development

  Celator Pharmaceuticals, Inc. and The Leukemia & Lymphoma Society Announce Positive Data from Phase 2b Study of CPX-351 at the American Society of Hematology Annual Meeting

  December 12, 2011

   · 

  1 min read
• Pharm Country

  The University City Science Center Release: Three Pennsylvania Universities Receive Awards to Bridge the Funding Gap

  December 12, 2011

   · 

  1 min read
• Drug Development

  Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company Highlight Pivotal Data on ADCETRIS™ (Brentuximab Vedotin) in Relapsed or Refractory Systemic ALCL at American Society of Hematology Annual Meeting

  December 12, 2011

   · 

  1 min read
• Drug Development

  Immunomedics, Inc. Reports Subcutaneous Injections of Low-Dose Veltuzumab Produced High Rates of Response in Relapsed Immune Thrombocytopenia

  December 12, 2011

   · 

  1 min read
• Biotech Beach

  Apricus Biosciences’ Vitaros(R) Podium Presentation Named Best Clinical Presentation 2011 (Male Sexual Disorder) by the Scientific Committee of the Congress for the European Society of Sexual Medicine Meeting in Milan

  December 12, 2011

   · 

  1 min read
• Pharmacyclics, Inc. Reports Interim Phase II Trial Results for BTK Inhibitor PCI-32765 in Mantle Cell Lymphoma at American Society of Hematology (ASH) Annual Meeting

  December 12, 2011

   · 

  1 min read
• Business

  DiaGenic ASA: Financial Calendar for 2012

  December 12, 2011

   · 

  1 min read
• “China Forum II” to Lead off 5th Annual OneMedForum

  December 12, 2011

   · 

  1 min read
• Drug Development

  BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies

  December 12, 2011

   · 

  1 min read